CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN AS NEOADJUVANT THERAPY FOR LOCALLY ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA (ESPRIT): A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH

被引：0
|
作者：
Ma, Jianqun [1 ]
Zhang, Jinfeng [1 ]
Yang, Yingnan [1 ]
Zheng, Dayong [1 ]
Wang, Xiaoyuan [1 ]
Liang, Hao [1 ]
Zhang, Luquan [1 ]
Xin, Yanzhong [1 ]
Ling, Xiaodong [1 ]
Fang, Chengyuan [1 ]
Jiang, Hao [1 ]
Meng, Hongxue [1 ]
Zheng, Wei [1 ]
机构：
[1] Harbin Med Univ, Affiliated Canc Hosp, Harbin, Peoples R China
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.405
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
405
引用
收藏
页码：A436 / A436
页数：1
相关论文
共 50 条
  • [1] Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase II, single-arm, exploratory research
    Ma, J.
    Zhang, J.
    Yang, Y.
    Zheng, D.
    Wang, X.
    Liang, H.
    Zhang, L.
    Xin, Y.
    Ling, X.
    Fang, C.
    Jiang, H.
    Meng, H.
    Zheng, W.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [2] Camrelizumab combined with paclitaxel and nedaplatin as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma (ESPRIT): A phase., single-arm, exploratory research.
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] CAMRELIZUMAB COMBINED WITH PACLITAXEL AND NEDAPLATIN IN THE FIRST-LINE TREATMENT OF LOCALLY ADVANCED/ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA: A PHASE II, SINGLE-ARM, EXPLORATORY RESEARCH
    Ma, Jianqun
    Zhang, Jinfeng
    Yang, Yingnan
    Zheng, Dayong
    Wang, Xiaoyuan
    Liang, Hao
    Zhang, Luquan
    Xin, Yanzhong
    Ling, Xiaodong
    Fang, Chengyuan
    Jiang, Hao
    Zheng, Wei
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A437 - A437
  • [4] Camrelizumab combined with paclitaxel and nedaplatin in the first-line treatment of locally advanced/advanced esophageal squamous cell carcinoma: A phase II, single-arm, exploratory research
    Wang, X.
    Ma, J.
    Zhang, J.
    Yang, Y.
    Zheng, D.
    Liang, H.
    Zhang, L.
    Xin, Y.
    Ling, X.
    Fang, C.
    Jiang, H.
    Zheng, W.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S1400 - S1400
  • [5] Neoadjuvant camrelizumab combined with paclitaxel and nedaplatin for locally advanced esophageal squamous cell carcinoma: a single-arm phase 2 study (cohort study)
    Yang, Yingnan
    Zhang, Jinfeng
    Meng, Hongxue
    Ling, Xiaodong
    Wang, Xiaoyuan
    Xin, Yanzhong
    Jiang, Hao
    Zhang, Luquan
    Fang, Chengyuan
    Liang, Hao
    Ma, Jianqun
    Zhu, Jinhong
    [J]. INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (03) : 1430 - 1440
  • [6] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Yang, Guozhen
    Su, Xiaodong
    Huang, Yuanheng
    Luo, Guangyu
    Wang, Zhiqiang
    Cai, Peiqiang
    Zheng, Yating
    Bei, Ting
    Huang, Mengli
    Bai, Yuezong
    He, Haoqiang
    Xiang, Jin
    Cai, Muyan
    Zhong, Jiudi
    Guo, Qiyu
    Zhang, Xu
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [7] Intensive cycles of neoadjuvant camrelizumab combined with chemotherapy in locally advanced esophageal squamous cell carcinoma: a single-arm, phase II trial
    Guozhen Yang
    Xiaodong Su
    Yuanheng Huang
    Guangyu Luo
    Zhiqiang Wang
    Peiqiang Cai
    Yating Zheng
    Ting Bei
    Mengli Huang
    Yuezong Bai
    Haoqiang He
    Jin Xiang
    Muyan Cai
    Jiudi Zhong
    Qiyu Guo
    Xu Zhang
    [J]. Journal of Translational Medicine, 21
  • [8] Camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma (ESCC): A single-arm, phase II trial
    Gong, Lei
    Yang, Yueyang
    Zhang, Hongdian
    Qiao, Yufeng
    Wang, Haitong
    Ren, Peng
    Tang, Peng
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [9] Multicenter, single-arm, phase II trial of camrelizumab and chemotherapy as neoadjuvant treatment for locally advanced esophageal squamous cell carcinoma
    Liu, Jun
    Yang, Yang
    Liu, Zhichao
    Fu, Xiaolong
    Cai, Xiaoyue
    Li, Hongxuan
    Zhu, Li
    Shen, Yan
    Zhang, Hong
    Sun, Yifeng
    Chen, Hezhong
    Yu, Bentong
    Zhang, Renquan
    Shao, Jinchen
    Zhang, Ming
    Li, Zhigang
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (03)
  • [10] Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol
    Maohui Chen
    Yizhou Huang
    Shuliang Zhang
    Taidui Zeng
    Guanglei Huang
    Chun Chen
    Bin Zheng
    [J]. Trials, 24 (1)
12345